Aveanna Healthcare Q3 Revenue Rises 11.8%; Raises 2026 Financial Outlook
Aveanna Healthcare (AVAH) reported Q3 2026 revenue of $695.5M, up 11.8% YoY, with net income of $45.5M. Adjusted EBITDA rose 25.0% to $100.1M. The company raised full-year 2026 revenue guidance to over $2.695B and Adjusted EBITDA to over $374M, citing strong operating momentum.
How this was made
The 30-second read
Why it matters
Earnings beat and guidance raise are likely to support a price rally, though debt levels and interest‑rate exposure remain concerns.
Market read
First‑time earnings and guidance disclosure for AVAH, providing fresh data for traders.
What to watch
Potential impact of interest‑rate caps and debt levels on future cash flow.
Background
Aveanna Healthcare Holdings Inc. reported Q3 2026 results, showing revenue growth across all segments and raised its full‑year outlook.
Ticker impact
Q3 2026 results posted with 11.8% revenue growth and raised full-year 2026 revenue and Adjusted EBITDA guidance.
likely upward pressure as market prices in higher revenue and EBITDA outlook
First report of earnings and guidance, material numbers for a listed health‑care provider.
Market effects
May lift sentiment for the home‑care and health‑services sector.
US health‑care stocks could see modest gains.
Limited to U.S. listed health‑care providers.
Counterpoint
Guidance raise is modest; high leverage and interest‑rate exposure could limit upside.
Key entities
- companyAveanna Healthcare Holdings Inc.
NASDAQ‑listed home‑care provider.

